P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY

Míreanna comhchosúla

• Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
  de réir: Sikander Ailawadhi, et al.
  Foilsithe / Cruthaithe: (2024-11-01)
• Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect® MM Registry
  de réir: Hans C. Lee, et al.
  Foilsithe / Cruthaithe: (2021-07-01)
• Connect MM Registry as a national reference for United States multiple myeloma patients
  de réir: Sikander Ailawadhi, et al.
  Foilsithe / Cruthaithe: (2020-01-01)
• Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM
  de réir: Sundar Jagannath, et al.
  Foilsithe / Cruthaithe: (2018-07-01)
• Lenalidomide-Associated ITP
  de réir: Christina I. Herold, et al.
  Foilsithe / Cruthaithe: (2011-01-01)